Targeting BCR-ABL Oncoprotein for Leukemia Therapy: Current Biotechnology and Future Perspectives

By Shen Min   Ping Dou Q.  

Current Biotechnology, Vol. 1, Iss. 2, 2012-06 ,pp. : 175-183

Bentham Science Publishers

Access to resources Recommend Favorite

Transcriptional Activation of Human LIM-HOX Gene, hLH-2, in Chronic Myelogenous Leukemia Is Due to a cis -Acting Effect of Bcr-Abl

By Wu H.K.   Minden M.D.  

Biochemical and Biophysical Research Communications, Vol. 233, Iss. 3, 1997-04 ,pp. : 806-812

Elsevier

Access to resources Recommend Favorite

Transcriptional Activation of Human LIM-HOX Gene hLH-2 in Chronic Myelogenous Leukemia Is Due to a cis -Acting Effect of Bcr-Abl

By Wu H.K.   Minden M.D.  

Biochemical and Biophysical Research Communications, Vol. 234, Iss. 3, 1997-05 ,pp. : 742-747

Elsevier

Access to resources Recommend Favorite

Regulation of Bcl-2 Gene Expression by BCR-ABL is Mediated by Ras

By Sánchez-García I.   Martín-Zanca D.  

Journal of Molecular Biology, Vol. 267, Iss. 2, 1997-03 ,pp. : 225-228

Academic Press

Access to resources Recommend Favorite

BCR/ABL downregulates DNA-PK_CS-dependent and upregulates backup non-homologous end joining in leukemic cells

By Poplawski Tomasz   Blasiak Janusz  

Molecular Biology Reports, Vol. 37, Iss. 5, 2010-06 ,pp. : 2309-2315

Springer Publishing Company

Access to resources Recommend Favorite